125 related articles for article (PubMed ID: 3068260)
21. Heparin free dialysis: comparative data and results in high risk patients.
Caruana RJ; Raja RM; Bush JV; Kramer MS; Goldstein SJ
Kidney Int; 1987 Jun; 31(6):1351-5. PubMed ID: 3613407
[TBL] [Abstract][Full Text] [Related]
22. Anticoagulation with prostacyclin and heparin during continuous venovenous hemofiltration.
Langenecker SA; Felfernig M; Werba A; Mueller CM; Chiari A; Zimpfer M
Crit Care Med; 1994 Nov; 22(11):1774-81. PubMed ID: 7956281
[TBL] [Abstract][Full Text] [Related]
23. Heparin-free renal replacement therapy for chronic hemodialyzed patients at high risk for bleeding: a comparison of on-line predilution hemodiafiltration with conventional hemodialysis.
Brunot V; Serre JE; Mourad G; Klouche K; Pernin V
Hemodial Int; 2018 Oct; 22(4):463-473. PubMed ID: 29745004
[TBL] [Abstract][Full Text] [Related]
24. Nafamostat mesilate: a regional anticoagulant for hemodialysis in patients at high risk for bleeding.
Akizawa T; Koshikawa S; Ota K; Kazama M; Mimura N; Hirasawa Y
Nephron; 1993; 64(3):376-81. PubMed ID: 8341382
[TBL] [Abstract][Full Text] [Related]
25. Neutrophil adhesiveness during prostacyclin and heparin hemodialysis.
Spagnuolo PJ; Bass SH; Smith MC; Danviriyasup K; Dunn MJ
Blood; 1982 Oct; 60(4):924-9. PubMed ID: 7052162
[TBL] [Abstract][Full Text] [Related]
26. Results of the HepZero study comparing heparin-grafted membrane and standard care show that heparin-grafted dialyzer is safe and easy to use for heparin-free dialysis.
Laville M; Dorval M; Fort Ros J; Fay R; Cridlig J; Nortier JL; Juillard L; Dębska-Ślizień A; Fernández Lorente L; Thibaudin D; Franssen C; Schulz M; Moureau F; Loughraieb N; Rossignol P
Kidney Int; 2014 Dec; 86(6):1260-7. PubMed ID: 25007166
[TBL] [Abstract][Full Text] [Related]
27. [Heparin-free hemodialysis in chronic patients for temporary management of conditions with a high risk of bleeding].
Stradtmann H; Förster S; Jalinski W
Z Urol Nephrol; 1988 Jul; 81(7):449-53. PubMed ID: 3176720
[TBL] [Abstract][Full Text] [Related]
28. Hemorrhage during high-risk hemodialysis using controlled heparinization.
Swartz RD
Nephron; 1981; 28(2):65-9. PubMed ID: 7290274
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of anticoagulation with heparin versus heparin plus epoprostenol in patients undergoing extracorporeal liver support with Prometheus.
Krisper P; Tiran B; Fliser D; Haditsch B; Stadlbauer V; Otto R; Ernst T; Kretschmer U; Stauber RE; Haller H; Holzer H; Manns MP; Rifai K
Artif Organs; 2010 Jan; 34(1):84-8. PubMed ID: 19663866
[TBL] [Abstract][Full Text] [Related]
30. Influence of prostacyclin infusion on haemodialysis efficiency and blood cells.
Kuźniewski M; Sułowicz W
Int Urol Nephrol; 1992; 24(5):555-63. PubMed ID: 1459834
[TBL] [Abstract][Full Text] [Related]
31. Effect of heparin and prostacyclin/heparin infusion on platelet aggregation in hemodialyzed patients.
Kuźniewski M; Sułowicz W; Hanicki Z; Kus J; Nowogrodzka-Zagórska M; Kostka-Trabka E; Bieroń K; Debińska-Kieć A
Nephron; 1990; 56(2):174-8. PubMed ID: 2243573
[TBL] [Abstract][Full Text] [Related]
32. Heparin-free hemodialysis with an oral anti-platelet agent.
Teraoka S; Naganuma S; Takahashi K; Ota K
ASAIO J; 1992; 38(3):M560-3. PubMed ID: 1457921
[TBL] [Abstract][Full Text] [Related]
33. Use of low-dose low molecular weight heparin in hemodialysis.
Lai KN; Wang AY; Ho K; Szeto CC; Li M; Wong LK; Yu AW
Am J Kidney Dis; 1996 Nov; 28(5):721-6. PubMed ID: 9158210
[TBL] [Abstract][Full Text] [Related]
34. Effects of citrate acid concentrate (citrasate®) on heparin N requirements and hemodialysis adequacy: a multicenter, prospective noninferiority trial.
Sands JJ; Kotanko P; Segal JH; Ho CH; Usvat L; Young A; Carter M; Sergeyeva O; Korth L; Maunsell E; Zhu Y; Krishnan M; Diaz-Buxo JA
Blood Purif; 2012; 33(1-3):199-204. PubMed ID: 22269855
[TBL] [Abstract][Full Text] [Related]
35. [Prostacyclin versus regional heparinisation during haemodialysis (author's transl)].
Hory B; Saunier F; Roy C; Renevier A; Kieffer Y; Saint-Hillier Y; Perol C
Nouv Presse Med; 1982 Jul 10-17; 11(32):2393-7. PubMed ID: 7050907
[TBL] [Abstract][Full Text] [Related]
36. A comparison of prostacyclin and heparin on hemodialyses in dogs.
Gross M; Bush H; McTigue H; Hamburger RJ; Flamenbaum W
Prostaglandins; 1981 Jun; 21(6):879-88. PubMed ID: 7027320
[TBL] [Abstract][Full Text] [Related]
37. [Prevention of thrombogenesis in the extracorporeal circuit of hemodialysis with a low molecular heparin: standardization of the dosage with a better hemorrhagic risk/effectiveness ratio].
Barata JD; Oliveira C; Bruges M; Gusmão L; Santana A; Ponce P; Simões J; Freire I; Crespo F; da Silva AN
Acta Med Port; 1992 Feb; 5(2):65-70. PubMed ID: 1317657
[TBL] [Abstract][Full Text] [Related]
38. An evaluation of four modes of low-dose anticoagulation during intermittent haemodialysis.
Skagerlind MSE; Stegmayr BG
Eur J Clin Pharmacol; 2018 Mar; 74(3):267-274. PubMed ID: 29198062
[TBL] [Abstract][Full Text] [Related]
39. Effect of heparin and prostacyclin-heparin infusion on blood coagulation in haemodialysed patients.
Kuźniewski M; Sułowicz W; Lisiewicz J
Int Urol Nephrol; 1991; 23(1):89-96. PubMed ID: 1938222
[TBL] [Abstract][Full Text] [Related]
40. Vitamin E-Coated and Heparin-Coated Dialyzer Membranes for Heparin-Free Hemodialysis: A Multicenter, Randomized, Crossover Trial.
Islam MS; Hassan ZA; Chalmin F; Vido S; Berrada M; Verhelst D; Donnadieu P; Moranne O; Esnault VL
Am J Kidney Dis; 2016 Nov; 68(5):752-762. PubMed ID: 27344212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
